248 related articles for article (PubMed ID: 31287389)
1. Perfusion CT to Assess Response to Neoadjuvant Chemotherapy and Radiation Therapy in Pancreatic Ductal Adenocarcinoma: Initial Experience.
Hamdy A; Ichikawa Y; Toyomasu Y; Nagata M; Nagasawa N; Nomoto Y; Sami H; Sakuma H
Radiology; 2019 Sep; 292(3):628-635. PubMed ID: 31287389
[TBL] [Abstract][Full Text] [Related]
2. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
Panda A; Garg I; Truty MJ; Kline TL; Johnson MP; Ehman EC; Suman G; Anaam DA; Kemp BJ; Johnson GB; Halfdanarson TR; Venkatesh SK; Fidler JL; Goenka AH
AJR Am J Roentgenol; 2021 Sep; 217(3):730-740. PubMed ID: 33084382
[No Abstract] [Full Text] [Related]
3. CT perfusion as a potential biomarker for pancreatic ductal adenocarcinoma during routine staging and restaging.
O'Malley RB; Cox D; Soloff EV; Zečević M; Green S; Coveler A; Busey JM; Wang CL
Abdom Radiol (NY); 2022 Nov; 47(11):3770-3781. PubMed ID: 35972550
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of perfusion CT to assess response to neoadjuvant combined chemoradiotherapy in patients with locally advanced rectal cancer.
Curvo-Semedo L; Portilha MA; Ruivo C; Borrego M; Leite JS; Caseiro-Alves F
Acad Radiol; 2012 Feb; 19(2):203-13. PubMed ID: 22130088
[TBL] [Abstract][Full Text] [Related]
5. Volumetric parameters of 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography/computed tomography can predict histopathologic treatment response after neoadjuvant chemoradiotherapy in pancreatic adenocarcinoma.
Sakane M; Tatsumi M; Hori M; Onishi H; Tsuboyama T; Nakamoto A; Ota T; Eguchi H; Wakasa K; Hatazawa J; Tomiyama N
Eur J Radiol; 2017 Sep; 94():64-69. PubMed ID: 28712692
[TBL] [Abstract][Full Text] [Related]
6. Locally advanced pancreatic adenocarcinoma: reassessment of response with CT after neoadjuvant chemotherapy and radiation therapy.
Cassinotto C; Mouries A; Lafourcade JP; Terrebonne E; Belleannée G; Blanc JF; Lapuyade B; Vendrely V; Laurent C; Chiche L; Wagner T; Sa-Cunha A; Gaye D; Trillaud H; Laurent F; Montaudon M
Radiology; 2014 Oct; 273(1):108-16. PubMed ID: 24960211
[TBL] [Abstract][Full Text] [Related]
7. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience.
Bellomi M; Petralia G; Sonzogni A; Zampino MG; Rocca A
Radiology; 2007 Aug; 244(2):486-93. PubMed ID: 17641369
[TBL] [Abstract][Full Text] [Related]
8. Volumetric CT perfusion assessment of treatment response in head and neck squamous cell carcinoma: Comparison of CT perfusion parameters before and after chemoradiation therapy.
Rana L; Sharma S; Sood S; Singh B; Gupta MK; Minhas RS; Jhobta A; Bhatia V; Venkat B
Eur J Radiol Open; 2015; 2():46-54. PubMed ID: 26937435
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Response to Neoadjuvant Therapy Using CT Texture Analysis in Patients With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma.
Borhani AA; Dewan R; Furlan A; Seiser N; Zureikat AH; Singhi AD; Boone B; Bahary N; Hogg ME; Lotze M; Zeh HJ; Tublin ME
AJR Am J Roentgenol; 2020 Feb; 214(2):362-369. PubMed ID: 31799875
[No Abstract] [Full Text] [Related]
10. Efficacy of perfusion CT in differentiating of pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis and characterization of isoattenuating pancreatic lesions.
Aslan S; Nural MS; Camlidag I; Danaci M
Abdom Radiol (NY); 2019 Feb; 44(2):593-603. PubMed ID: 30225610
[TBL] [Abstract][Full Text] [Related]
11. Imaging-based biomarkers: Changes in the tumor interface of pancreatic ductal adenocarcinoma on computed tomography scans indicate response to cytotoxic therapy.
Amer AM; Zaid M; Chaudhury B; Elganainy D; Lee Y; Wilke CT; Cloyd J; Wang H; Maitra A; Wolff RA; Varadhachary G; Overman MJ; Lee JE; Fleming JB; Tzeng CW; Katz MH; Holliday EB; Krishnan S; Minsky BD; Herman JM; Taniguchi CM; Das P; Crane CH; Le O; Bhosale P; Tamm EP; Koay EJ
Cancer; 2018 Apr; 124(8):1701-1709. PubMed ID: 29370450
[TBL] [Abstract][Full Text] [Related]
12. Absolute CT perfusion parameter values after the neoadjuvant chemoradiotherapy of the squamous cell esophageal carcinoma correlate with the histopathologic tumor regression grade.
Djuric-Stefanovic A; Micev M; Stojanovic-Rundic S; Pesko P; Saranovic Dj
Eur J Radiol; 2015 Dec; 84(12):2477-84. PubMed ID: 26467704
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic adenocarcinoma: dynamic 64-slice helical CT with perfusion imaging.
Xu J; Liang Z; Hao S; Zhu L; Ashish M; Jin C; Fu D; Ni Q
Abdom Imaging; 2009 Nov; 34(6):759-66. PubMed ID: 19672566
[TBL] [Abstract][Full Text] [Related]
14. CT Texture Analysis of Ductal Adenocarcinoma Downstaged After Chemotherapy.
Ciaravino V; Cardobi N; DE Robertis R; Capelli P; Melisi D; Simionato F; Marchegiani G; Salvia R; D'Onofrio M
Anticancer Res; 2018 Aug; 38(8):4889-4895. PubMed ID: 30061265
[TBL] [Abstract][Full Text] [Related]
15. Does CT overestimate extra-pancreatic perineural invasion in patients with pancreatic ductal adenocarcinoma following neoadjuvant chemoradiation therapy?
Noda Y; Pisuchpen N; Parakh A; Srinivas-Rao S; Kinowaki Y; Mino-Kenudson M; Kambadakone AR
Br J Radiol; 2024 Feb; 97(1155):607-613. PubMed ID: 38305574
[TBL] [Abstract][Full Text] [Related]
16. Assessment of tumor vascularization in pancreatic adenocarcinoma using 128-slice perfusion computed tomography imaging.
Delrue L; Blanckaert P; Mertens D; Cesmeli E; Ceelen WP; Duyck P
J Comput Assist Tomogr; 2011; 35(4):434-8. PubMed ID: 21765297
[TBL] [Abstract][Full Text] [Related]
17. An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma.
Sun Z; Cheng X; Ge Y; Shao L; Xuan Y; Yan G
Gastric Cancer; 2018 May; 21(3):413-420. PubMed ID: 28871423
[TBL] [Abstract][Full Text] [Related]
18. Response assessment in pancreatic ductal adenocarcinoma: role of imaging.
Baliyan V; Kordbacheh H; Parakh A; Kambadakone A
Abdom Radiol (NY); 2018 Feb; 43(2):435-444. PubMed ID: 29243123
[TBL] [Abstract][Full Text] [Related]
19. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations.
Sahani DV; Kalva SP; Hamberg LM; Hahn PF; Willett CG; Saini S; Mueller PR; Lee TY
Radiology; 2005 Mar; 234(3):785-92. PubMed ID: 15734934
[TBL] [Abstract][Full Text] [Related]
20. Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth.
Mayer P; Fritz F; Koell M; Skornitzke S; Bergmann F; Gaida MM; Hackert T; Maier-Hein K; Laun FB; Kauczor HU; Grenacher L; Klauß M; Stiller W
Cancer Imaging; 2021 Jan; 21(1):13. PubMed ID: 33468259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
